SoftBank leads $1.1 bln round for Roivant Sciences

Healthcare company Roivant Sciences has secured $1.1 billion in funding. SoftBank led the round. Cooley LLP advised Softbank on the transaction.

9 August 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles